{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:43:31Z","timestamp":1792172611057,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.4065\/82.9.1052","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T21:33:17Z","timestamp":1232659997000},"page":"1052-1059","source":"Crossref","is-referenced-by-count":324,"title":["Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.4065","volume":"82","author":[{"given":"Hefziba","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.4065\/82.9.1052_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003508","article-title":"Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV","author":"Grimwade","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"10.4065\/82.9.1052_bib2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.4065\/82.9.1052_bib3","series-title":"Principles and Practice of Infectious Diseases","first-page":"3080","article-title":"Pneumocystis species","author":"Walzer","year":"2005"},{"issue":"5","key":"10.4065\/82.9.1052_bib4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjc.6602412","article-title":"An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital","volume":"92","author":"Worth","year":"2005","journal-title":"Br J Cancer"},{"issue":"1","key":"10.4065\/82.9.1052_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.4065\/82.9.1052_bib6","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.4065\/82.9.1052_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002281-199905000-00004","article-title":"Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections","volume":"11","author":"Singer","year":"1999","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.4065\/82.9.1052_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.10.1.86","article-title":"Infections in solid-organ transplant recipients","volume":"10","author":"Patel","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.4065\/82.9.1052_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/CMR.17.4.770-782.2004","article-title":"Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients","volume":"17","author":"Rodriguez","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"10.4065\/82.9.1052_bib10","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/art.11301","article-title":"Infections and anti-tumor necrosis factor alpha therapy","volume":"48","author":"Ellerin","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.4065\/82.9.1052_bib11","author":"US Food and Drug Administration"},{"issue":"RR15","key":"10.4065\/82.9.1052_bib12","first-page":"1","article-title":"Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"53","author":"Benson","year":"2004","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"10.4065\/82.9.1052_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection","volume":"332","author":"Bozzette","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/82.9.1052_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00042560-199706010-00002","article-title":"Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients","volume":"15","author":"Bucher","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.4065\/82.9.1052_bib15","series-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]","year":"2005"},{"issue":"suppl D","key":"10.4065\/82.9.1052_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/26.suppl_D.137","article-title":"Infection prophylaxis in neutropenic patients with acute leukaemia\u2014a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole\/colistin","volume":"26","author":"Arning","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.4065\/82.9.1052_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1702004","article-title":"A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim\/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation","volume":"24","author":"Colby","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.4065\/82.9.1052_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(90)90337-D","volume":"89","author":"Fox","year":"1990","journal-title":"Am J Med"},{"issue":"3","key":"10.4065\/82.9.1052_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006454-198505000-00012","article-title":"Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia","volume":"4","author":"Goorin","year":"1985","journal-title":"Pediatr Infect Dis"},{"key":"10.4065\/82.9.1052_bib20","article-title":"Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients: a double-blind, randomized controlled trial","author":"Hibberd","year":"1992","journal-title":"Online J Curr Clin Trials"},{"issue":"26","key":"10.4065\/82.9.1052_bib21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"297","author":"Hughes","year":"1977","journal-title":"N Engl J Med"},{"issue":"26","key":"10.4065\/82.9.1052_bib22","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","article-title":"Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"316","author":"Hughes","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/82.9.1052_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/AAC.34.2.215","article-title":"Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy","volume":"34","author":"Liang","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.4065\/82.9.1052_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00007890-199308000-00021","article-title":"Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole","volume":"56","author":"Olsen","year":"1993","journal-title":"Transplantation"},{"issue":"11","key":"10.4065\/82.9.1052_bib25","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/0277-5379(87)90449-4","article-title":"Prospective randomized comparison of two prophylactic regimens with trimethoprim-sulfamethoxazole in leukemic children: a two year study","volume":"23","author":"Rossi","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"4","key":"10.4065\/82.9.1052_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1086\/520432","article-title":"Randomized trial of weekly sulfadoxine\/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation","volume":"29","author":"Torre-Cisneros","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.4065\/82.9.1052_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1097-0142(19870101)59:1<19::AID-CNCR2820590108>3.0.CO;2-B","article-title":"Effect of trimethoprim\/sulfamethoxazole prophylaxis on outcome of childhood lymphocytic leukemia: a Pediatric Oncology Group Study","volume":"59","author":"van Eys","year":"1987","journal-title":"Cancer"},{"issue":"6","key":"10.4065\/82.9.1052_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00005792-199711000-00004","article-title":"Pneumocystis carinii infection in heart transplant recipients: efficacy of a weekend prophylaxis schedule","volume":"76","author":"Munoz","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.4065\/82.9.1052_bib29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/clinids\/4.6.1119","article-title":"Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience","volume":"4","author":"Meyers","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"6","key":"10.4065\/82.9.1052_bib30","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.2820360912","article-title":"Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis","volume":"36","author":"Hughes","year":"1975","journal-title":"Cancer"},{"issue":"6","key":"10.4065\/82.9.1052_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/82.9.1052_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2334-4-42","article-title":"Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention","volume":"4","author":"Sowden","year":"2004","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.4065\/82.9.1052_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/j.1875-9114.1995.tb04378.x","article-title":"A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity","volume":"15","author":"Jick","year":"1995","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.4065\/82.9.1052_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2125.1997.00590.x","article-title":"Hospitalization for serious blood and skin disorders following co-trimoxazole","volume":"43","author":"Myers","year":"1997","journal-title":"Br J Clin Pharmacol"},{"issue":"12, pt 1","key":"10.4065\/82.9.1052_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.4065\/82.9.1052_bib36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.259.8.1185","article-title":"Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS","volume":"259","author":"Fischl","year":"1988","journal-title":"JAMA"},{"issue":"2","key":"10.4065\/82.9.1052_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens","volume":"156","author":"Ioannidis","year":"1996","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.4065\/82.9.1052_bib38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"issue":"RR10","key":"10.4065\/82.9.1052_bib39","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients [published correction appears in MMWR Recomm Rep. 2004;53(19):396]","volume":"49","author":"Centers for Disease Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.4065\/82.9.1052_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10156-004-0368-5","article-title":"Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy","volume":"15","author":"Ogawa","year":"2005","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.4065\/82.9.1052_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005590.pub2","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","author":"Green","year":"2007","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611613657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611613657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T06:51:57Z","timestamp":1709967117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611613657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0025619611613657"],"URL":"https:\/\/doi.org\/10.4065\/82.9.1052","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}